Search results
Results from the WOW.Com Content Network
Bedinvetmab, sold under the brand name Librela is a canine monoclonal antibody used for the control of pain associated with osteoarthritis in dogs. [3] [4] [5] Librela is sponsored by Zoetis.
Zoetis Inc. (/zō-EH-tis/ [4]) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. [ 5 ] [ 4 ] [ 6 ] The company was a subsidiary of Pfizer , [ 7 ] the world's largest drug maker , but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company.
The pharmaceutical company that developed and sells Librela is Zoetis, a spinoff of Pfizer that focuses on animals. Studies showed that some of the dogs who received Librela were in less pain and ...
Many pet owners have found that their dogs have had severe reactions to the medication. The reactions have ranged from serious illness, the loss of a dog's ability to walk or stand, and even death.
Maropitant (INN; [3] brand name: Cerenia, used as maropitant citrate , is a neurokinin-1 (NK 1) receptor antagonist developed by Zoetis specifically for the treatment of motion sickness and vomiting in dogs. It was approved by the FDA in 2007, for use in dogs [4] [5] and in 2012, for cats. [6]
The medication is produced by the pet drug firm Zoetis and was approved by the FDA last year. The dog medication Librela is likely sickening and killing dogs, the FDA warned. Ermolaev Alexandr ...
Lokivetmab, trade name Cytopoint, is a monoclonal antibody used to treat atopic dermatitis in dogs. [1] It acts against interleukin 31 (IL-31), [2] which is a cytokine involved in causing itchiness (pruritus). [2] Lokivetmab is administered by subcutaneous injection; each dose is effective for four to eight weeks. [3]
Dirlotapide is a drug used to treat obesity in dogs. [1] It is manufactured by Pfizer and Zoetis and marketed under the brand name Slentrol. [citation needed]It works as a gut-selective microsomal triglyceride transfer protein (MTTP or MTP) inhibitor. [2]